Skip to main content

Table 1 Treatments received by the patients and SLEDAI score at the time of analysis

From: Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients

 

Patient characteristics

   

Patient

Sex

Daily prednisone dose*

Other treatment

SLEDAI**

%CD27+IgD+

1

F

LOW

HCQ

4

7

2

F

MEDIUM

CYC

16

9

3

F

HIGH

-

8

1

4

F

LOW

-

4

3

5

F

-

HCQ

2

7

6

F

LOW

-

15

3

7

F

-

HCQ

0

4

8

F

HIGH

AZA

10

5

9

F

-

-

0

8

10

F

-

HCQ

0

11

11

F

-

HCQ

0

17

12

F

LOW

MMF

10

4

13

F

HIGH

AZA

1

3

14

F

-

HCQ

2

3

15

F

MEDIUM

HCQ

8

8

16

F

HIGH

HCQ

0

13

17

F

-

-

0

8

18

M

LOW

HCQ

4

12

19

F

LOW

HCQ

2

6

20

F

LOW

-

0

2

21

F

MEDIUM

HCQ

5

7

22

F

HIGH

HCQ

19

9

23

F

LOW

-

8

2

24

F

LOW

-

4

21

25

F

-

-

0

7

26

F

LOW

AZA

1

7

27

M

LOW

AZA

0

13

28

F

-

HCQ

0

18

29

F

-

-

11

6

30

F

-

HCQ

13

3

31

F

LOW

AZA

0

4

32

M

-

-

0

6

33

F

-

HCQ

4

8

34

F

LOW

HCQ

8

4

35

M

HIGH

-

8

6

36

F

-

HCQ

0

11

37

F

-

HCQ

0

25

38

F

-

-

3

8

39

F

-

HCQ

1

27

40

F

-

AZA/RX

0

2

41

F

-

-

0

24

42

F

-

HCQ

0

4

43

F

-

-

0

6

44

F

-

MTX

0

8

45

F

-

-

0

13

46

F

-

-

0

28

47

F

-

HCQ

0

2

48

F

LOW

HCQ

0

16

49

F

-

HCQ

1

5

50

F

-

-

0

3

51

F

-

HCQ/MTX

0

8

52

F

-

HCQ

0

17

53

F

-

-

0

33

54

F

-

HCQ

0

6

55

F

LOW

MMF

4

15

56

F

-

HCQ

0

8

57

M

-

LFN

4

31

58

F

-

LFN

0

10

59

F

LOW

MTX

4

5

60

F

LOW

MTX

0

5

61

F

-

-

0

4

62

F

-

HCQ

1

7

63

F

LOW

MMF

0

15

64

F

-

-

0

3

65

F

MEDIUM

HCQ/MTX

2

2

66

M

LOW

-

0

13

67

F

LOW

-

0

13

68

F

-

-

0

17

69

F

-

AZA

1

4

  1. *LOW (≤10 mg/day); MEDIUM (≤30 mg/day); HIGH (>30 mg/day).
  2. AZA: azathioprine; HQC: hydroxychloroquine; CYC: cyclophosphamide; LFN: leflunomide MMF: mycophenolate mofetil; MTX: methotrexate; RX: rituximab; **SLEDAI: Systemic Lupus Erythematosus Disease Activity Index.